Leap Therapeutics price target lowered to $5.50 from $7 at H.C. Wainwright
PremiumThe FlyLeap Therapeutics price target lowered to $5.50 from $7 at H.C. Wainwright
6M ago
Leap Therapeutics reports Q1 EPS (51c), consensus (58c)
Premium
The Fly
Leap Therapeutics reports Q1 EPS (51c), consensus (58c)
6M ago
LPTX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LPTX Earnings this Week: How Will it Perform?
6M ago
Leap Therapeutics price target lowered to $9 from $11 at Baird
PremiumThe FlyLeap Therapeutics price target lowered to $9 from $11 at Baird
8M ago
Leap Therapeutics’ Success Tied to Partner NovaRock’s Commitment in Asian Markets
Premium
Company Announcements
Leap Therapeutics’ Success Tied to Partner NovaRock’s Commitment in Asian Markets
8M ago
Leap Therapeutics files $200M mixed securities shelf
Premium
The Fly
Leap Therapeutics files $200M mixed securities shelf
8M ago
Leap Therapeutics price target lowered to $12 from $20 at Mizuho
PremiumThe FlyLeap Therapeutics price target lowered to $12 from $20 at Mizuho
12M ago
Leap Therapeutics price target lowered to $11 from $20 at Baird
Premium
The Fly
Leap Therapeutics price target lowered to $11 from $20 at Baird
12M ago
Leap Therapeutics reports Q3 EPS (51c), consensus (58c)
Premium
The Fly
Leap Therapeutics reports Q3 EPS (51c), consensus (58c)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100